Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. Drug Class
1.2.3. Route of Administration
1.2.4. Distribution Channel
1.2.5. Estimates and Forecasts Timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis (Model 1)
1.7.2. Volume Price Analysis (Model 2)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type
2.2.2. Drug Class
2.2.3. Route of Administration
2.2.4. Distribution Channel
2.3. Competitive Insights
Chapter 3. U.S. Inflammatory Bowel Disease Treatment Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. U.S. Inflammatory Bowel Disease Treatment Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrant
3.3.1.5. Competitive Rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political Landscape
3.3.2.2. Technological Landscape
3.3.2.3. Economic Landscape
Chapter 4. U.S. Inflammatory Bowel Disease Treatment Market: Type Estimates & Trend Analysis
4.1. Type Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. U.S. Inflammatory Bowel Disease Treatment Market by Type Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
4.4.1. Crohn's Disease
4.4.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
4.4.2. Ulcerative Colitis
4.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
Chapter 5. U.S. Inflammatory Bowel Disease Treatment Market: Drug Class Estimates & Trend Analysis
5.1. Drug Class Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. U.S. Inflammatory Bowel Disease Treatment Market by Drug Class Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
5.4.1. Aminosalicylates
5.4.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
5.4.2. Corticosteroids
5.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
5.4.3. TNF Inhibitors
5.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
5.4.4. IL Inhibitors
5.4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
5.4.5. Anti-integrin
5.4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
5.4.6. JAK Inhibitors
5.4.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
5.4.7. Others
5.4.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
Chapter 6. U.S. Inflammatory Bowel Disease Treatment Market: Route of Administration Estimates & Trend Analysis
6.1. Route of Administration Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. U.S. Inflammatory Bowel Disease Treatment Market by Route of Administration Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
6.4.1. Oral
6.4.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
6.4.2. Injectable
6.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
Chapter 7. U.S. Inflammatory Bowel Disease Treatment Market: Distribution Channel Estimates & Trend Analysis
7.1. Distribution Channel Market Share, 2023 & 2030
7.2. Segment Dashboard
7.3. U.S. Inflammatory Bowel Disease Treatment Market by Distribution Channel Outlook
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
7.4.1. Hospital Pharmacy
7.4.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
7.4.2. Retail Pharmacy
7.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
7.4.3. Online Pharmacy
7.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
Chapter 8. U.S. Inflammatory Bowel Disease Treatment Market: Region Estimates & Trend Analysis
8.1. Regional Market Share, 2023 & 2030
8.2. U.S. Inflammatory Bowel Disease Treatment Market by Region Outlook
8.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
8.3.1. West
8.3.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
8.3.2. Midwest
8.3.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
8.3.3. Northeast
8.3.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
8.3.4. Southwest
8.3.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
8.3.5. Southeast
8.3.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, by Key Market Participants
9.2. Company/Competition Categorization
9.3. Vendor Landscape
9.3.1. List of Key Distributors and Channel Partners
9.3.2. Key Customers
9.3.3. Key Company Heat Map Analysis, 2023
9.4. Company Profiles
9.4.1. Biogen
9.4.1.1. Company Overview
9.4.1.2. Financial Performance
9.4.1.3. Product Benchmarking
9.4.1.4. Strategic Initiatives
9.4.2. Novartis AG
9.4.2.1. Company Overview
9.4.2.2. Financial Performance
9.4.2.3. Product Benchmarking
9.4.2.4. Strategic Initiatives
9.4.3. Eli Lilly & Company
9.4.3.1. Company Overview
9.4.3.2. Financial Performance
9.4.3.3. Product Benchmarking
9.4.3.4. Strategic Initiatives
9.4.4. UCB S.A.
9.4.4.1. Company Overview
9.4.4.2. Financial Performance
9.4.4.3. Product Benchmarking
9.4.4.4. Strategic Initiatives
9.4.5. Celltrion Inc.
9.4.5.1. Company Overview
9.4.5.2. Financial Performance
9.4.5.3. Product Benchmarking
9.4.5.4. Strategic Initiatives
9.4.6. Merck & Co., Inc.
9.4.6.1. Company Overview
9.4.6.2. Financial Performance
9.4.6.3. Product Benchmarking
9.4.6.4. Strategic Initiatives
9.4.7. Johnson & Johnson Services, Inc.
9.4.7.1. Company Overview
9.4.7.2. Financial Performance
9.4.7.3. Product Benchmarking
9.4.7.4. Strategic Initiatives
List of Tables
Table 1 List of Abbreviations
Table 2 U.S. Inflammatory Bowel Disease Treatment Market, by Type, 2018-2030 (USD Million)
Table 3 U.S. Inflammatory Bowel Disease Treatment Market, by Drug Class, 2018-2030 (USD Million)
Table 4 U.S. Inflammatory Bowel Disease Treatment Market, by Route of Administration, 2018-2030 (USD Million)
Table 5 U.S. Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
Table 6 U.S. Inflammatory Bowel Disease Treatment Market, by Region, 2018-2030 (USD Million)
List of Figures
Figure 1 Market Research Process
Figure 2 Data Triangulation Techniques
Figure 3 Primary Research Pattern
Figure 4 Market Research Approaches
Figure 5 Value-chain-based Sizing & Forecasting
Figure 6 QFD Modeling for Market Share Assessment
Figure 7 Market Formulation & Validation
Figure 8 U.S. Inflammatory Bowel Disease Treatment Market: Market Outlook
Figure 9 U.S. Inflammatory Bowel Disease Treatment Competitive Insights
Figure 10 Parent Market Outlook
Figure 11 Related/ancillary Market Outlook
Figure 12 Penetration and Growth Prospect Mapping
Figure 13 U.S. Inflammatory Bowel Disease Treatment Market Driver Impact
Figure 14 U.S. Inflammatory Bowel Disease Treatment Market Restraint Impact
Figure 15 U.S. Inflammatory Bowel Disease Treatment Market: Type Movement Analysis
Figure 16 U.S. Inflammatory Bowel Disease Treatment Market: Type Outlook and Key Takeaways
Figure 17 Crohn's Disease Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 18 Ulcerative Colitis Estimates and Forecasts, 2018-2030 (USD Million)
Figure 19 U.S. Inflammatory Bowel Disease Treatment Market: Drug Class Movement Analysis
Figure 20 U.S. Inflammatory Bowel Disease Treatment Market: Drug Class Outlook and Key Takeaways
Figure 21 Aminosalicylates Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 22 Corticosteroids Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 23 TNF Inhibitors Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 24 IL Inhibitors Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 25 Anti-integrin Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 26 JAK Inhibitors Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 27 U.S. Inflammatory Bowel Disease Treatment Market: Route of Administration Movement Analysis
Figure 28 U.S. Inflammatory Bowel Disease Treatment Market: Route of Administration Outlook and Key Takeaways
Figure 29 Oral Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 30 Injectable Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 31 U.S. Inflammatory Bowel Disease Treatment Market: Distribution Channel Movement Analysis
Figure 32 U.S. Inflammatory Bowel Disease Treatment Market: Distribution Channel Outlook and Key Takeaways
Figure 33 Hospital Pharmacy Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 34 Retail Pharmacy Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 35 Online Pharmacy Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 36 U.S. Inflammatory Bowel Disease Treatment Market: Regional Movement Analysis
Figure 37 U.S. Inflammatory Bowel Disease Treatment Market: Regional Outlook and Key Takeaways
Figure 38 West Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 39 Midwest Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 40 Northeast Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 41 Southwest Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 42 Southeast Market Estimates and Forecasts, 2018-2030 (USD Million)
